Last reviewed · How we verify

NCT04971174

Outcomes of Periodontal Regenerative Treatment

Completed Last updated 23 February 2026
What this trial tests

trial in Periodontitis in 126 participants. Completed in 31 January 2026.

Timeline
30 September 2022
Primary endpoint
31 January 2026
31 January 2026

Quick facts

Lead sponsorQueen Mary University of London
StatusCompleted
Study typeOBSERVATIONAL
Enrollment126
Start date30 September 2022
Primary completion31 January 2026
Estimated completion31 January 2026
Sites1 location across United Kingdom

Conditions studied

Sponsor

Queen Mary University of London

Who can join

18 and older, any sex, with Periodontitis or Intrabony Periodontal Defect. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this recall study is to evaluate outcomes of surgical regenerative treatment of periodontal defects in a cohort of patient previously treated for gum disease at the Royal London Hospital as part of their periodontal care.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Periodontitis

Currently open trials in the same condition.

Other Queen Mary University of London trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04971174.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing